Anna Zlotina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anna Zlotina has a total of 158 co-authors. Here are the top co-authors by number of shared publications:
- Alla Krasikova
Laboratory of Cell Nucleus Structure and Dynamics, Saint-Petersburg State University, Saint-Petersburg, Russia
14 shared publications - Anna A. Kostareva
Almazov National Medical Research Centre
12 shared publications - Aleksandr Khudiakov
Center For Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics Istituto Auxologico Italiano IRCCS Milan Italy
7 shared publications Anna Kostareva
Almazov National Medical Research Centre, Saint-Petersburg, Russia
6 shared publicationsAlexey Sergushichev
Computer Technologies Laboratory, ITMO University, Saint Petersburg, Russia
5 shared publications- Elena Gaginskaya
Saint Petersburg State University, Saint Petersburg, Russian Federation
4 shared publications
Latest Publications
- 30 October 2026
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 20 (S4) , S535-S554
Optimal Exosome–Liposome Ratio in Hybrid Particles for Efficient Delivery of mRNA and siRNA to Human Cardiac Cells
Objective: Cardiovascular disease remains the leading global cause of mortality, driving an urgent need for novel therapeutics capable of addressing both acute and chronic pathologies. RNA-based strategies—particularly RNA interference and mRNA-based protein replacement—hold considerable promise in this context. However, their clinical translation is critically hindered by the lack of efficient delivery systems capable of transfecting hard-to-transfect primary cardiac cells, which are essential for preclinical evaluation. In this study, we optimized a hybrid delivery platform combining human serum-derived exosomes with 2X3-DOPE cationic liposomes for the transport of both small interfering RNA (siRNA) and messenger RNA (mRNA) into primary human cardiac cells. Methods: Chemically synthesized siRNA and eGFP-encoding mRNA were used as cargo. Delivery efficiency was assessed via target gene knockdown (qPCR) for siRNA and eGFP expression (flow cytometry) for mRNA, using both CMCs and iPSC-derived cardiomyocytes. We systematically varied the exosome-to-liposome molar ratio and assembly order to identify optimal formulation conditions. Results and Discussion: For siRNA, the highest silencing activity was achieved at a 1/0.5 ratio, with particles formed by pre-assembling exosomes and liposomes prior to siRNA loading. In contrast, mRNA delivery was most effective at a 1/0.2 ratio, requiring initial complexation of liposomes with mRNA before exosome addition. These conditions were validated in iPSC-cardiomyocytes. Conclusions: Collectively, our findings establish a robust formulation framework for exosome-liposome hybrids tailored to cardiac cell types. The optimized platforms will now be evaluated in vivo following intravenous and intrapericardial administration in murine models, supporting the future development of RNA therapeutics for inherited and acquired myocardial disorders.
- 30 October 2026
- Published by Pleiades Publishing Ltd in Cell and Tissue Biology
- Vol. 20 (S4) , S535-S554
Optimal Exosome–Liposome Ratio in Hybrid Particles for Efficient Delivery of mRNA and siRNA to Human Cardiac Cells
Objective: Cardiovascular disease remains the leading global cause of mortality, driving an urgent need for novel therapeutics capable of addressing both acute and chronic pathologies. RNA-based strategies—particularly RNA interference and mRNA-based protein replacement—hold considerable promise in this context. However, their clinical translation is critically hindered by the lack of efficient delivery systems capable of transfecting hard-to-transfect primary cardiac cells, which are essential for preclinical evaluation. In this study, we optimized a hybrid delivery platform combining human serum-derived exosomes with 2X3-DOPE cationic liposomes for the transport of both small interfering RNA (siRNA) and messenger RNA (mRNA) into primary human cardiac cells. Methods: Chemically synthesized siRNA and eGFP-encoding mRNA were used as cargo. Delivery efficiency was assessed via target gene knockdown (qPCR) for siRNA and eGFP expression (flow cytometry) for mRNA, using both CMCs and iPSC-derived cardiomyocytes. We systematically varied the exosome-to-liposome molar ratio and assembly order to identify optimal formulation conditions. Results and Discussion: For siRNA, the highest silencing activity was achieved at a 1/0.5 ratio, with particles formed by pre-assembling exosomes and liposomes prior to siRNA loading. In contrast, mRNA delivery was most effective at a 1/0.2 ratio, requiring initial complexation of liposomes with mRNA before exosome addition. These conditions were validated in iPSC-cardiomyocytes. Conclusions: Collectively, our findings establish a robust formulation framework for exosome-liposome hybrids tailored to cardiac cell types. The optimized platforms will now be evaluated in vivo following intravenous and intrapericardial administration in murine models, supporting the future development of RNA therapeutics for inherited and acquired myocardial disorders.
- Open Access
- 9 September 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1862793
Genomic spectrum of congenital heart disease combined with kidney and urinary tract anomalies uncovered by exome sequencing and array-CGH
Congenital heart disease (CHD) combined with anomalies of the kidney and urinary tract (CAKUT) belongs to severe clinical conditions that represent isolated cases or can be part of complex inherited syndromes. To date, knowledge of the genetic basis of cardio-renal birth defects is very limited. Using chromosomal microarray analysis and exome sequencing, we investigated the spectrum of copy number variations (CNVs) and point genetic variants in a pediatric cohort of 30 patients presenting with combined CHD and CAKUT. Two patients possessed a pathogenic deletion in the 22q11.2 genomic region, well-known as the DiGeorge/velocardiofacial syndrome locus. Four other patients harbored rare copy number gains, which included one of the dosage-sensitive genes: DHFR (5q14.1), NPHP1 (2q13), NNT (5p12), and MCTP2 (15q26.2). In six children, novel or previously described causative variants were detected in the genes associated with orphan monogenic disorders such as Kabuki ( KMT2D) , Noonan ( PTPN11 ), Adams-Oliver ( NOTCH1 ), and Alagille ( JAG1 ) syndromes, as well as SALL4 - and MED13 -related syndromes. Furthermore, potentially disease-contributing variants were identified in the genes that primarily code for cardiac transcription factors, chromatin remodeling proteins, Notch- or BMP- signaling molecules, and components of cilia. Notably, two children had loss-of-function variants in ROBO1 , encoding one of the receptors of the SLIT/ROBO signaling pathway. In vitro studies on cardiac mesenchymal cells demonstrated a dramatically diminished expression level of ROBO1 in a patient with novel compound heterozygous variants c.541_542del (p.Val181CysfsTer18) and c.657+4A>G and a moderately reduced ROBO1 expression in a patient with a heterozygous stop-gain variant c.2758C>T (p.Arg920Ter), which suggests a haploinsufficiency mechanism. Together, our findings underlined the utility of early cytogenetic screening for the 22q11.2 deletion among children with cardio-renal malformations and confirmed the importance of rare single-nucleotide variants in the genes involved in cardiogenesis and kidney development. In particular, ROBO1 can be regarded as a candidate gene associated with combined heart and kidney structural defects and should be included in appropriate diagnostic gene-sequencing panels. The results support the usefulness of WES and array-based comparative genomic hybridization (array-CGH) analysis for new candidate gene identification, more accurate diagnosis, and family genetic counseling.
- 9 September 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1862793
Open AccessGenomic spectrum of congenital heart disease combined with kidney and urinary tract anomalies uncovered by exome sequencing and array-CGH
Congenital heart disease (CHD) combined with anomalies of the kidney and urinary tract (CAKUT) belongs to severe clinical conditions that represent isolated cases or can be part of complex inherited syndromes. To date, knowledge of the genetic basis of cardio-renal birth defects is very limited. Using chromosomal microarray analysis and exome sequencing, we investigated the spectrum of copy number variations (CNVs) and point genetic variants in a pediatric cohort of 30 patients presenting with combined CHD and CAKUT. Two patients possessed a pathogenic deletion in the 22q11.2 genomic region, well-known as the DiGeorge/velocardiofacial syndrome locus. Four other patients harbored rare copy number gains, which included one of the dosage-sensitive genes: DHFR (5q14.1), NPHP1 (2q13), NNT (5p12), and MCTP2 (15q26.2). In six children, novel or previously described causative variants were detected in the genes associated with orphan monogenic disorders such as Kabuki ( KMT2D) , Noonan ( PTPN11 ), Adams-Oliver ( NOTCH1 ), and Alagille ( JAG1 ) syndromes, as well as SALL4 - and MED13 -related syndromes. Furthermore, potentially disease-contributing variants were identified in the genes that primarily code for cardiac transcription factors, chromatin remodeling proteins, Notch- or BMP- signaling molecules, and components of cilia. Notably, two children had loss-of-function variants in ROBO1 , encoding one of the receptors of the SLIT/ROBO signaling pathway. In vitro studies on cardiac mesenchymal cells demonstrated a dramatically diminished expression level of ROBO1 in a patient with novel compound heterozygous variants c.541_542del (p.Val181CysfsTer18) and c.657+4A>G and a moderately reduced ROBO1 expression in a patient with a heterozygous stop-gain variant c.2758C>T (p.Arg920Ter), which suggests a haploinsufficiency mechanism. Together, our findings underlined the utility of early cytogenetic screening for the 22q11.2 deletion among children with cardio-renal malformations and confirmed the importance of rare single-nucleotide variants in the genes involved in cardiogenesis and kidney development. In particular, ROBO1 can be regarded as a candidate gene associated with combined heart and kidney structural defects and should be included in appropriate diagnostic gene-sequencing panels. The results support the usefulness of WES and array-based comparative genomic hybridization (array-CGH) analysis for new candidate gene identification, more accurate diagnosis, and family genetic counseling.
- Open Access
Functional and Expression Studies of iPSC-Derived Cardiomyocytes Carrying a Novel HCM-Associated MYPN Genetic Variant
Background/Objectives: Variants of MYPN, encoding a sarcomeric protein myopalladin, are associated with different types of cardiomyopathies and myopathies. However, the molecular mechanisms of MYPN-associated pathologies are still poorly understood. Methods: In this study, we generated induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient carrying a novel p.N989I (c.2966A>T) variant of MYPN and used iPSC-derived cardiomyocytes to examine the impact of the variant on biophysical characteristics and transcriptomic profile. Results: No significant changes in parameters of calcium transients, sodium current and action potential were found in iPSC-derived cardiomyocytes with the p.N989I (c.2966A>T) variant of MYPN compared to non-isogenic cells from an unrelated healthy donor. At the transcriptomic level, MYPN-N989I cardiomyocytes demonstrated an upregulation of genes linked to cell cycle, mitotic spindle, microtubule cytoskeleton organization, and myogenic program genes. Downregulation of sarcomeric, Z-disc- and cell junction-associated genes, as well as genes involved in ATP synthesis, oxidative phosphorylation, and the SRF-signaling pathway, was also revealed. Conclusions: Our data suggest that the p.N989I (c.2966A>T) variant of MYPN plays a dual role in hypertrophic cardiomyopathy pathogenesis, disrupting not only sarcomeric and cytoskeletal organization but also the regulation of the muscle gene program.
Open AccessFunctional and Expression Studies of iPSC-Derived Cardiomyocytes Carrying a Novel HCM-Associated MYPN Genetic Variant
Background/Objectives: Variants of MYPN, encoding a sarcomeric protein myopalladin, are associated with different types of cardiomyopathies and myopathies. However, the molecular mechanisms of MYPN-associated pathologies are still poorly understood. Methods: In this study, we generated induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient carrying a novel p.N989I (c.2966A>T) variant of MYPN and used iPSC-derived cardiomyocytes to examine the impact of the variant on biophysical characteristics and transcriptomic profile. Results: No significant changes in parameters of calcium transients, sodium current and action potential were found in iPSC-derived cardiomyocytes with the p.N989I (c.2966A>T) variant of MYPN compared to non-isogenic cells from an unrelated healthy donor. At the transcriptomic level, MYPN-N989I cardiomyocytes demonstrated an upregulation of genes linked to cell cycle, mitotic spindle, microtubule cytoskeleton organization, and myogenic program genes. Downregulation of sarcomeric, Z-disc- and cell junction-associated genes, as well as genes involved in ATP synthesis, oxidative phosphorylation, and the SRF-signaling pathway, was also revealed. Conclusions: Our data suggest that the p.N989I (c.2966A>T) variant of MYPN plays a dual role in hypertrophic cardiomyopathy pathogenesis, disrupting not only sarcomeric and cytoskeletal organization but also the regulation of the muscle gene program.
- Open Access
- 23 January 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (11) , 4567
Potential and prospects for using biomedical resource collections obtained from pediatric patients for clinics and research
Aim . To demonstrate the development and potential applications of biomedical resource collections of pediatric patient biomaterials, as well as the potential for their differentiated use for clinical and research purposes in a multidisciplinary hospital setting at a federal research center. Material and methods . The study included biomaterial from pediatric patients and their first-degree relatives, banked between 2016 and 2025 as part of research projects at the Almazov National Medical Research Center in the field of clinical genetics and pediatrics. Deoxyribonucleic acid (DNA) isolated from whole blood samples and dried blood spots was used for genetic testing using modern molecular genetic diagnostic methods. Results . The potential of using bioresource collections of pediatric patient biomaterial was demonstrated using familial cases of rare monogenic diseases, for which previously collected biomaterial from the biobank was used to establish a diagnosis and determine follow-up strategies for family members, identify risks to future offspring, and receive advance data on the management of patients with specific hereditary syndromes. Additionally, the ability to predict new phenotypes associated with a known gene, and conversely, to uncover the relationship of new genes with a known phenotype, was demonstrated using examples of familial diseases, where biobank biomaterial enabled segregation analysis. Using biomaterial from cohorts of patients with a specific pathology, the potential for developing novel diagnostic algorithms and laboratory test systems, a differentiated approach to selecting a targeted genetic panel for diagnosis, and the identification of new clinical and genetic disease features was showed. A founder mutation was showed to be identified in a pathology determined in a specific ethnic group, with the potential to describe the onset time and geographic distribution. Conclusion . The creation of bioresource collections obtained from pediatric populations is a complex, yet extremely important, clinically necessary, and promising scientific task. Its implementation facilitates translational research aimed at improving diagnostic methods, understanding the pathogenesis and progression of childhood diseases, and the influence of environmental factors on their development. It also facilitates the search for new genetic causes of hereditary pathologies and the description of new phenotypes associated with known genes. It also identifies predictors of disease severity and prognosis. In the long term, it facilitates the search for novel therapeutic approaches and understanding the disease pathogenesis in adults.
- 23 January 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (11) , 4567
Open AccessPotential and prospects for using biomedical resource collections obtained from pediatric patients for clinics and research
Aim . To demonstrate the development and potential applications of biomedical resource collections of pediatric patient biomaterials, as well as the potential for their differentiated use for clinical and research purposes in a multidisciplinary hospital setting at a federal research center. Material and methods . The study included biomaterial from pediatric patients and their first-degree relatives, banked between 2016 and 2025 as part of research projects at the Almazov National Medical Research Center in the field of clinical genetics and pediatrics. Deoxyribonucleic acid (DNA) isolated from whole blood samples and dried blood spots was used for genetic testing using modern molecular genetic diagnostic methods. Results . The potential of using bioresource collections of pediatric patient biomaterial was demonstrated using familial cases of rare monogenic diseases, for which previously collected biomaterial from the biobank was used to establish a diagnosis and determine follow-up strategies for family members, identify risks to future offspring, and receive advance data on the management of patients with specific hereditary syndromes. Additionally, the ability to predict new phenotypes associated with a known gene, and conversely, to uncover the relationship of new genes with a known phenotype, was demonstrated using examples of familial diseases, where biobank biomaterial enabled segregation analysis. Using biomaterial from cohorts of patients with a specific pathology, the potential for developing novel diagnostic algorithms and laboratory test systems, a differentiated approach to selecting a targeted genetic panel for diagnosis, and the identification of new clinical and genetic disease features was showed. A founder mutation was showed to be identified in a pathology determined in a specific ethnic group, with the potential to describe the onset time and geographic distribution. Conclusion . The creation of bioresource collections obtained from pediatric populations is a complex, yet extremely important, clinically necessary, and promising scientific task. Its implementation facilitates translational research aimed at improving diagnostic methods, understanding the pathogenesis and progression of childhood diseases, and the influence of environmental factors on their development. It also facilitates the search for new genetic causes of hereditary pathologies and the description of new phenotypes associated with known genes. It also identifies predictors of disease severity and prognosis. In the long term, it facilitates the search for novel therapeutic approaches and understanding the disease pathogenesis in adults.
- Open Access
- 22 December 2025
- Published by MDPI AG in Preprints.org
Functional and Expression Studies of iPSC-Derived Cardiomyocytes Carrying a Novel HCM-Associated MYPN Genetic Variant
Variants in MYPN encoding a sarcomeric protein, myopalladin, are associated with different types of cardiomyopathies and myopathies. However, molecular mechanisms of MYPN-associated pathologies are still poorly understood. In this study, we generated induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient carried a novel p.N989I (c.2966A>T) variant in MYPN and used iPSC-derived cardiomyocytes to examine the impact of the variant on biophysical characteristics and transcriptomic profile. No significant changes in parameters of calcium transient, sodium current and action potential were found in iPSC-derived cardiomyocytes with p.N989I (c.2966A>T) variant in MYPN compared to control cells from a healthy donor. At the transcriptomic level, MYPN-N989I cardiomyocytes demonstrated an upregulation of genes linked to cell cycle, division springle, microtubule cytoskeleton organization and myogenic program genes. A downregulation of sarcomeric, Z-disc- and cell junction-associated genes and genes involved in ATP synthesis, oxidative phosphorylation and SRF-signaling pathway was also revealed. Our data suggest that the p.N989I (c.2966A>T) variant in MYPN plays a dual role in hypertrophic cardiomyopathy pathogenesis, disrupting not only sarcomeric and cytoskeletal organization but also muscle gene program regulation.
- 22 December 2025
- Published by MDPI AG in Preprints.org
Open AccessFunctional and Expression Studies of iPSC-Derived Cardiomyocytes Carrying a Novel HCM-Associated MYPN Genetic Variant
Variants in MYPN encoding a sarcomeric protein, myopalladin, are associated with different types of cardiomyopathies and myopathies. However, molecular mechanisms of MYPN-associated pathologies are still poorly understood. In this study, we generated induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient carried a novel p.N989I (c.2966A>T) variant in MYPN and used iPSC-derived cardiomyocytes to examine the impact of the variant on biophysical characteristics and transcriptomic profile. No significant changes in parameters of calcium transient, sodium current and action potential were found in iPSC-derived cardiomyocytes with p.N989I (c.2966A>T) variant in MYPN compared to control cells from a healthy donor. At the transcriptomic level, MYPN-N989I cardiomyocytes demonstrated an upregulation of genes linked to cell cycle, division springle, microtubule cytoskeleton organization and myogenic program genes. A downregulation of sarcomeric, Z-disc- and cell junction-associated genes and genes involved in ATP synthesis, oxidative phosphorylation and SRF-signaling pathway was also revealed. Our data suggest that the p.N989I (c.2966A>T) variant in MYPN plays a dual role in hypertrophic cardiomyopathy pathogenesis, disrupting not only sarcomeric and cytoskeletal organization but also muscle gene program regulation.
- Open Access
- 23 August 2024
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 19 (1) , 1-23
Characterization of pathogenic genetic variants in Russian patients with primary ciliary dyskinesia using gene panel sequencing and transcript analysis
Background: Primary ciliary dyskinesia (PCD) is a group of rare genetically heterogeneous disorders caused by defective cilia and flagella motility. The clinical phenotype of PCD patients commonly includes chronic oto-sino-pulmonary disease, infertility, and, in about half of cases, laterality defects due to randomization of left–right body asymmetry. To date, pathogenic variants in more than 50 genes responsible for motile cilia structure and assembly have been reported in such patients. While multiple population-specific mutations have been described in PCD cohorts from different countries, the data on genetic spectrum of PCD in Russian population are still extremely limited. Results: The present study provides a comprehensive clinical and genetic characterization of 21 Russian families with PCD living in various country regions. Anomalies of ciliary beating in patients` respiratory epithelial cells were confirmed by high-speed video microscopy. In the most cases, custom-designed panel sequencing allowed to uncover causative variants in well-known or rarely mentioned PCD-related genes, including DNAH5, DNAH11, CFAP300, LRRC6, ZMYND10, CCDC103, HYDIN, ODAD4, DNAL1, and OFD1. The variations comprised common mutations, as well as novel genetic variants, some of which probably specific for Russian patients. Additional targeted analysis of mRNA transcripts from ciliated cells enabled us to specify functional effects of newly identified genetic variants in DNAH5 (c.2052+3G>T, c.3599-2A>G), HYDIN (c.10949-2A>G, c.1797C>G), and ZMYND10 (c.510+1G>C) on splicing process. In particular, the splice site variant c.2052+3G>T, detected in four unrelated families, resulted in skipping of exon 14 in DNAH5 transcripts and, according to haplotype analysis of affected probands, was proposed as an ancestral founder mutation in Udmurt population. Conclusions: The reported data provide a vital insight into genetic background of primary ciliary dyskinesia in the Russian population. The findings clearly illustrate the utility of gene panel sequencing coupled with transcriptional analysis in identification and clinical interpretation of novel genetic variants.
- 23 August 2024
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 19 (1) , 1-23
Open AccessCharacterization of pathogenic genetic variants in Russian patients with primary ciliary dyskinesia using gene panel sequencing and transcript analysis
Background: Primary ciliary dyskinesia (PCD) is a group of rare genetically heterogeneous disorders caused by defective cilia and flagella motility. The clinical phenotype of PCD patients commonly includes chronic oto-sino-pulmonary disease, infertility, and, in about half of cases, laterality defects due to randomization of left–right body asymmetry. To date, pathogenic variants in more than 50 genes responsible for motile cilia structure and assembly have been reported in such patients. While multiple population-specific mutations have been described in PCD cohorts from different countries, the data on genetic spectrum of PCD in Russian population are still extremely limited. Results: The present study provides a comprehensive clinical and genetic characterization of 21 Russian families with PCD living in various country regions. Anomalies of ciliary beating in patients` respiratory epithelial cells were confirmed by high-speed video microscopy. In the most cases, custom-designed panel sequencing allowed to uncover causative variants in well-known or rarely mentioned PCD-related genes, including DNAH5, DNAH11, CFAP300, LRRC6, ZMYND10, CCDC103, HYDIN, ODAD4, DNAL1, and OFD1. The variations comprised common mutations, as well as novel genetic variants, some of which probably specific for Russian patients. Additional targeted analysis of mRNA transcripts from ciliated cells enabled us to specify functional effects of newly identified genetic variants in DNAH5 (c.2052+3G>T, c.3599-2A>G), HYDIN (c.10949-2A>G, c.1797C>G), and ZMYND10 (c.510+1G>C) on splicing process. In particular, the splice site variant c.2052+3G>T, detected in four unrelated families, resulted in skipping of exon 14 in DNAH5 transcripts and, according to haplotype analysis of affected probands, was proposed as an ancestral founder mutation in Udmurt population. Conclusions: The reported data provide a vital insight into genetic background of primary ciliary dyskinesia in the Russian population. The findings clearly illustrate the utility of gene panel sequencing coupled with transcriptional analysis in identification and clinical interpretation of novel genetic variants.
- Open Access
- 1 March 2022
- Published by Elsevier in Stem Cell Research
- Vol. 59, 102640
Generation of iPSC line (FAMRCi009-A) from patient with familial progressive cardiac conduction disorder carrying genetic variant FLNC p.Val2264Met
- 1 March 2022
- Published by Elsevier in Stem Cell Research
- Vol. 59, 102640
Open AccessGeneration of iPSC line (FAMRCi009-A) from patient with familial progressive cardiac conduction disorder carrying genetic variant FLNC p.Val2264Met
- Open Access
- 20 November 2020
- Published by Springer Nature in BMC Medical Genomics
- Vol. 13 (1) , 1-9
A 300-kb microduplication of 7q36.3 in a patient with triphalangeal thumb-polysyndactyly syndrome combined with congenital heart disease and optic disc coloboma: a case report
Background: Triphalangeal thumb-polysyndactyly syndrome (TPT-PS) is a rare well-defined autosomal dominant disorder characterized by long thumbs with three phalanges combined with pre- and postaxial polydactyly/syndactyly of limbs. By now, the syndrome has been reported in several large families from different ethnic backgrounds, with a high degree of inter- and intrafamilial variability. The genome locus responsible for TPT-PS has been mapped to the 7q36.3 region harboring a long-range sonic hedgehog (SHH) regulatory sequence (ZRS). Both single-nucleotide variants and complete duplications of ZRS were shown to cause TPT-PS and similar limb phenotypes. TPT-PS usually forms as isolated limb pathology not associated with additional malformations, in particular, with cardiovascular abnormalities.Case presentation: Here we report on a rare Russian neonatal case of TPT-PS combined with severe congenital heart disease, namely double outlet right ventricle, and microphthalmia with optic disc coloboma. Pedigree analysis revealed TPT-PS of various expressivity in 10 family members throughout five generations, while the cardiac defect and the eye pathology were detected only in the proband. To extend the knowledge on genotype–phenotype spectrum of TPT-PS, the careful clinical and genomic analysis of the family was performed. High-resolution array-based comparative genomic hybridization (array-CGH) revealed a ~ 300 kb microduplication of 7q36.3 locus (arr[GRCh37] 7q36.3(156385810_156684811) × 3) that co-segregated with TPT-PS in the proband and her mother. The duplication encompassed three genes includingLMBR1, the intron 5 of which is known to harbor ZRS. Based on whole-exome sequencing data, no additional pathogenic mutations or variants of uncertain clinical significance were found in morbid cardiac genes or genes associated with a microphthalmia/anophthalmia/coloboma spectrum of ocular malformations.Conclusions: The results support the previous data, indicating that complete ZRS duplication underlies TPT-PS, and suggest a broader phenotypic impact of the 7q36.3 microduplication. Potential involvement of the 7q36.3 microduplication in the patient’s cardiac and eye malformations is discussed. However, the contribution of some additional genetic/epigenetic factors to the complex patient`s phenotype cannot be excluded entirely. Further comprehensive functional studies are needed to prove the possible involvement of the 7q36.3 locus in congenital heart disease and eye pathology.
- 20 November 2020
- Published by Springer Nature in BMC Medical Genomics
- Vol. 13 (1) , 1-9
Open AccessA 300-kb microduplication of 7q36.3 in a patient with triphalangeal thumb-polysyndactyly syndrome combined with congenital heart disease and optic disc coloboma: a case report
Background: Triphalangeal thumb-polysyndactyly syndrome (TPT-PS) is a rare well-defined autosomal dominant disorder characterized by long thumbs with three phalanges combined with pre- and postaxial polydactyly/syndactyly of limbs. By now, the syndrome has been reported in several large families from different ethnic backgrounds, with a high degree of inter- and intrafamilial variability. The genome locus responsible for TPT-PS has been mapped to the 7q36.3 region harboring a long-range sonic hedgehog (SHH) regulatory sequence (ZRS). Both single-nucleotide variants and complete duplications of ZRS were shown to cause TPT-PS and similar limb phenotypes. TPT-PS usually forms as isolated limb pathology not associated with additional malformations, in particular, with cardiovascular abnormalities.Case presentation: Here we report on a rare Russian neonatal case of TPT-PS combined with severe congenital heart disease, namely double outlet right ventricle, and microphthalmia with optic disc coloboma. Pedigree analysis revealed TPT-PS of various expressivity in 10 family members throughout five generations, while the cardiac defect and the eye pathology were detected only in the proband. To extend the knowledge on genotype–phenotype spectrum of TPT-PS, the careful clinical and genomic analysis of the family was performed. High-resolution array-based comparative genomic hybridization (array-CGH) revealed a ~ 300 kb microduplication of 7q36.3 locus (arr[GRCh37] 7q36.3(156385810_156684811) × 3) that co-segregated with TPT-PS in the proband and her mother. The duplication encompassed three genes includingLMBR1, the intron 5 of which is known to harbor ZRS. Based on whole-exome sequencing data, no additional pathogenic mutations or variants of uncertain clinical significance were found in morbid cardiac genes or genes associated with a microphthalmia/anophthalmia/coloboma spectrum of ocular malformations.Conclusions: The results support the previous data, indicating that complete ZRS duplication underlies TPT-PS, and suggest a broader phenotypic impact of the 7q36.3 microduplication. Potential involvement of the 7q36.3 microduplication in the patient’s cardiac and eye malformations is discussed. However, the contribution of some additional genetic/epigenetic factors to the complex patient`s phenotype cannot be excluded entirely. Further comprehensive functional studies are needed to prove the possible involvement of the 7q36.3 locus in congenital heart disease and eye pathology.
- Open Access
Two New Cases of Hypertrophic Cardiomyopathy and Skeletal Muscle Features Associated with ALPK3 Homozygous and Compound Heterozygous Variants
Hypertrophic cardiomyopathy associated with damaging variants in the ALPK3 gene is a fairly recent discovery, and only a small number of patients have been described thus far. Here we present two additional patients with hypertrophic cardiomyopathy caused by biallelic variants in ALPK3. Genetic investigation was performed using a targeted gene panel consisting of known cardiomyopathy-associated genes and whole exome sequencing. The patients showed a large difference in the age of onset, and both presented with extracardiac features that are often seen in ALPK3 patients. The patient with the later onset showed milder extracardiac symptoms, such as decreased muscle tone and distal muscular dystrophy, but had fast progression of cardiac complications leading to the need of heart transplantation. This study further elucidates the variability of both symptoms and age of onset among these patients.
Open AccessTwo New Cases of Hypertrophic Cardiomyopathy and Skeletal Muscle Features Associated with ALPK3 Homozygous and Compound Heterozygous Variants
Hypertrophic cardiomyopathy associated with damaging variants in the ALPK3 gene is a fairly recent discovery, and only a small number of patients have been described thus far. Here we present two additional patients with hypertrophic cardiomyopathy caused by biallelic variants in ALPK3. Genetic investigation was performed using a targeted gene panel consisting of known cardiomyopathy-associated genes and whole exome sequencing. The patients showed a large difference in the age of onset, and both presented with extracardiac features that are often seen in ALPK3 patients. The patient with the later onset showed milder extracardiac symptoms, such as decreased muscle tone and distal muscular dystrophy, but had fast progression of cardiac complications leading to the need of heart transplantation. This study further elucidates the variability of both symptoms and age of onset among these patients.
- Open Access
- 3 August 2020
- Published by Springer Nature in Molecular Cytogenetics
- Vol. 13 (1) , 1-15
Mapping epigenetic modifications on chicken lampbrush chromosomes
Background: The epigenetic regulation of genome is crucial for implementation of the genetic program of ontogenesis through establishing and maintaining differential gene expression. Thus mapping of various epigenetic modifications to the genome is relevant for studying the regulation of gene expression. Giant transcriptionally active lampbrush chromosomes are an established tool for high resolution physical mapping of the genome and its epigenetic modifications. This study is aimed at characterizing the epigenetic status of compact chromatin domains (chromomeres) of chicken lampbrush macrochromosomes.Results: Distribution of three epigenetic modifications – 5-methylcytosine, histone H3 trimethylated at lysine 9 and hyperacetylated histone H4 – along the axes of chicken lampbrush chromosomes 1–4, Z and W was analyzed in details. Enrichment of chromatin domains with the investigated epigenetic modifications was indicated on the cytological chromomere-loop maps for corresponding chicken lampbrush chromosomes. Heterogeneity in the distribution of 5-methylcytosine and histone H3 trimethylated at lysine 9 along the chromosome axes was revealed.Conclusions: On examples of certain chromomeres of chicken lampbrush chromosomes 1, 3, 4 and W we demonstrated that a combination of immunofluorescent staining and fluorescence in situ hybridization allows to relate the epigenetic status and a DNA sequence context of individual chromomeres.
- 3 August 2020
- Published by Springer Nature in Molecular Cytogenetics
- Vol. 13 (1) , 1-15
Open AccessMapping epigenetic modifications on chicken lampbrush chromosomes
Background: The epigenetic regulation of genome is crucial for implementation of the genetic program of ontogenesis through establishing and maintaining differential gene expression. Thus mapping of various epigenetic modifications to the genome is relevant for studying the regulation of gene expression. Giant transcriptionally active lampbrush chromosomes are an established tool for high resolution physical mapping of the genome and its epigenetic modifications. This study is aimed at characterizing the epigenetic status of compact chromatin domains (chromomeres) of chicken lampbrush macrochromosomes.Results: Distribution of three epigenetic modifications – 5-methylcytosine, histone H3 trimethylated at lysine 9 and hyperacetylated histone H4 – along the axes of chicken lampbrush chromosomes 1–4, Z and W was analyzed in details. Enrichment of chromatin domains with the investigated epigenetic modifications was indicated on the cytological chromomere-loop maps for corresponding chicken lampbrush chromosomes. Heterogeneity in the distribution of 5-methylcytosine and histone H3 trimethylated at lysine 9 along the chromosome axes was revealed.Conclusions: On examples of certain chromomeres of chicken lampbrush chromosomes 1, 3, 4 and W we demonstrated that a combination of immunofluorescent staining and fluorescence in situ hybridization allows to relate the epigenetic status and a DNA sequence context of individual chromomeres.